Table 1.
Diagnostic evaluation summary.
| Lab | Result | Reference |
|---|---|---|
| Presenting labs | ||
| WBC | 4,400 cells/ml | 3,200–9,800 cells/ml |
| Hemoglobin | 8.4 g/dl | 13.7–17.3 g/dl |
| Platelets | 18,000/ml | 150,000–450,000/ml |
| Reticulocyte count (%) | 17,200/ml (0.65) | 28,000–134,000/ml (0.70–2.0) |
| Folate | 11.4 ng/ml | > 6.5 ng/ml |
| B12 | 404 pg/ml | 123–730 pg/ml |
| Iron | 220 μg/dl | 50–160 μg/dl |
| Total Iron binding capacity | 248 μg/dl | 261–478 μg/dl |
| Copper | 131 μg/dl | 63–121 μg/dl |
| Lactate dehydrogenase | 151 U/L | 100–200 U/L |
| Haptoglobin | 50 mg/dl | 30–200 mg/dl |
| Immunoglobulin M | 7 mg/dl | 57–273 mg/dl |
| Immunoglobulin G | 122 mg/dl | 588–1,573 mg/dl |
| Immunoglobulin A | 12 mg/dl | 46–287 mg/dl |
| Flow cytometrya | ||
| WBC | 2,000 cells/ml | 3,200–9,800 cells/ml |
| ALC (%) | 268 cells/ml (13.4) | 600–4,200 cells/ml (10–50) |
| CD3+ (%) | 222 cells/μl (83.0) | 1,543–1,729 cells/ml (76.1–78.3)b |
| CD4+ (%) | 107 cells/μl (40.1) | 942–1,066 (45.7–48.5)b |
| CD8+ (%) | 88 cells/μl (32.9) | 544–637 (26.4–28.9)b |
| CD19+ (%) | 3 cells/μl (1.3) | 232–281 (11.1–12.8)b |
| NK-cells (%) | 37 cells/μl (13.8) | 188–336 (9.0–10.8)b |
| CD3/CD45RA+ (%) | 67 cells/μl (30.3) | (20.3–44.1) |
| CD3/CD45RO+ (%) | 78 cells/μl (34.9) | (30.4–51.3) |
Abnormal values are bolded.
a
Flow cytometry results 2-weeks following presenting labs.
b
Reference ranges from Valiathan et al. (17).